MXPA03005395A - Derivados de dihidroindol y tetrahidroquinolina. - Google Patents

Derivados de dihidroindol y tetrahidroquinolina.

Info

Publication number
MXPA03005395A
MXPA03005395A MXPA03005395A MXPA03005395A MXPA03005395A MX PA03005395 A MXPA03005395 A MX PA03005395A MX PA03005395 A MXPA03005395 A MX PA03005395A MX PA03005395 A MXPA03005395 A MX PA03005395A MX PA03005395 A MXPA03005395 A MX PA03005395A
Authority
MX
Mexico
Prior art keywords
dihydroindole
tetrahydroquinoline derivatives
tetrahydroquinoline
derivatives
Prior art date
Application number
MXPA03005395A
Other languages
English (en)
Spanish (es)
Inventor
Chucholowski Alexander
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA03005395A publication Critical patent/MXPA03005395A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
MXPA03005395A 2000-12-21 2001-12-12 Derivados de dihidroindol y tetrahidroquinolina. MXPA03005395A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128063 2000-12-21
PCT/EP2001/014620 WO2002050041A1 (en) 2000-12-21 2001-12-12 Dihydroindole and tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
MXPA03005395A true MXPA03005395A (es) 2003-09-25

Family

ID=8170751

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005395A MXPA03005395A (es) 2000-12-21 2001-12-12 Derivados de dihidroindol y tetrahidroquinolina.

Country Status (15)

Country Link
US (2) US6706751B2 (enExample)
EP (1) EP1358162B1 (enExample)
JP (1) JP4068459B2 (enExample)
KR (1) KR100530408B1 (enExample)
CN (1) CN1208322C (enExample)
AR (1) AR035408A1 (enExample)
AT (1) ATE317386T1 (enExample)
AU (2) AU1917602A (enExample)
BR (1) BR0116263A (enExample)
CA (1) CA2431100C (enExample)
DE (1) DE60117096T2 (enExample)
ES (1) ES2257381T3 (enExample)
MX (1) MXPA03005395A (enExample)
WO (1) WO2002050041A1 (enExample)
ZA (1) ZA200304646B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040522A1 (es) 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
HRP20050181A2 (en) * 2002-08-29 2006-03-31 Merck & Co. Inc. Indoles having anti-diabetic activity
JP4479656B2 (ja) * 2003-08-08 2010-06-09 宇部興産株式会社 アルキニル基置換縮合ヘテロ環化合物及びその製法並びにそれを使用する有機エレクトロルミネッセンス素子
TWI329102B (en) * 2006-08-15 2010-08-21 Nat Health Research Institutes Thiourea compounds and method for inhibiting hepatitis c virus infection
WO2008124300A1 (en) * 2007-04-10 2008-10-16 National Health Research Institutes Hepatitis c virus inhibitors
WO2008154091A1 (en) * 2007-06-08 2008-12-18 National Health Research Institutes Thiourea derivatives
TWI361808B (en) * 2008-01-08 2012-04-11 Nat Health Research Institutes Imidazolidinone and imidazolidinethione derivatives
US8198284B2 (en) * 2008-04-30 2012-06-12 National Health Research Institutes Treatment of neurodegenerative disorders with thiourea compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997542A (en) * 1975-06-23 1976-12-14 Sterling Drug Inc. 1-(Halogenated-acetyl)-1,2,3,4-tetrahydro-6-quinolinols and esters thereof
NZ227042A (en) 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US5288749A (en) 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
TW438774B (en) 1993-07-14 2001-06-07 Hoffmann La Roche Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines
AU1608397A (en) 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
DE19727117A1 (de) 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist

Also Published As

Publication number Publication date
JP2004519441A (ja) 2004-07-02
US7102007B2 (en) 2006-09-05
AR035408A1 (es) 2004-05-26
CN1481366A (zh) 2004-03-10
ATE317386T1 (de) 2006-02-15
CA2431100C (en) 2009-03-24
BR0116263A (pt) 2003-12-30
US20030004156A1 (en) 2003-01-02
DE60117096D1 (de) 2006-04-20
EP1358162A1 (en) 2003-11-05
KR100530408B1 (ko) 2005-11-22
WO2002050041A1 (en) 2002-06-27
AU2002219176B2 (en) 2006-02-09
JP4068459B2 (ja) 2008-03-26
US20050020624A1 (en) 2005-01-27
KR20030063453A (ko) 2003-07-28
ZA200304646B (en) 2004-09-13
EP1358162B1 (en) 2006-02-08
AU1917602A (en) 2002-07-01
CN1208322C (zh) 2005-06-29
CA2431100A1 (en) 2002-06-27
US6706751B2 (en) 2004-03-16
DE60117096T2 (de) 2006-11-23
ES2257381T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
MXPA03001928A (es) Derivados de quinolina y quinazolina.
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
ZA200007593B (en) Quinoline Derivatives.
GB2384776C (en) Phthalazinone derivatives
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
ZA200204390B (en) Caspase inhibitors and uses thereof.
AU9667901A (en) Mycoattractants and mycopesticides
AU9327501A (en) Quinolinone derivatives
HUP0301230A3 (en) Phenylpyridazine derivatives and drugs containing the same
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
MXPA03005395A (es) Derivados de dihidroindol y tetrahidroquinolina.
ZA200005239B (en) Quinolin-4-yl derivatives I.
AU2002219176A1 (en) Dihydroindole and tetrahydroquinoline derivatives
MXPA03001951A (es) Pirroliminas y pirazoliminas fusionadas substituidas.
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
GB0026505D0 (en) Phthalazinone derivatives
IL154821A0 (en) DISCRIMINATION BETWEEN GnRH-I AND GnRH-II
MXPA03004687A (es) Derivados de indol y dihidroindol.
AU7815201A (en) Synthetic salicylihalamides, apicularens and derivatives thereof
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
ZA994369B (en) Acridin derivatives.

Legal Events

Date Code Title Description
FG Grant or registration